Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jalmira Mulchande, Sandra I. Simões, Maria M. Gaspar, Carla V. Eleutério, Rudi Oliveira, Maria E.M. Cruz, Rui Moreira & Jim Iley. (2011) Synthesis, stability, biochemical and pharmacokinetic properties of a new potent and selective 4-oxo-β-lactam inhibitor of human leukocyte elastase. Journal of Enzyme Inhibition and Medicinal Chemistry 26:2, pages 169-175.
Read now
Read now
Jean-Yves Winum, Andrea Scozzafava, Jean-Louis Montero & Claudiu T Supuran. (2006) The sulfamide motif in the design of enzyme inhibitors. Expert Opinion on Therapeutic Patents 16:1, pages 27-47.
Read now
Read now
. (2003) Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease. Expert Opinion on Therapeutic Patents 13:2, pages 267-272.
Read now
Read now
Articles from other publishers (20)
Abdeslem Bouzina, Yousra Ouafa Bouone, Omar Sekiou, Mohamed Aissaoui, Tan-Sothea Ouk, Abdelhak Djemel, Rachida Mansouri, Malika Ibrahim-Ouali, Zihad Bouslama & Nour-Eddine Aouf. (2023)
In vitro
antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues
. RSC Advances 13:28, pages 19567-19584.
Crossref
Crossref
B. S. Harish, Mamilla R. Charan Raja, Santanu Kar Mahapatra & Kiran Babu Uppuluri. (2020) Production Enhancement of an Anticoagulant Trypsin Inhibitor from Oceanimonas sp. BPMS22 and Its Anti-cancer Activity. International Journal of Peptide Research and Therapeutics 27:1, pages 197-208.
Crossref
Crossref
Jaden Jungho Jun, Divya Duscharla, Ramesh Ummanni, Paul R. Hanson & Sanjay V. Malhotra. (2021) Investigation on the Anticancer Activity of Symmetric and Unsymmetric Cyclic Sulfamides. ACS Medicinal Chemistry Letters 12:2, pages 202-210.
Crossref
Crossref
Justine Demay, Cécile Bernard, Anita Reinhardt & Benjamin Marie. (2019) Natural Products from Cyanobacteria: Focus on Beneficial Activities. Marine Drugs 17:6, pages 320.
Crossref
Crossref
B.S Harish & Kiran Babu Uppuluri. (2018) Microbial serine protease inhibitors and their therapeutic applications. International Journal of Biological Macromolecules 107, pages 1373-1387.
Crossref
Crossref
Jinrui Wei, Kun Liu, Faquan Lin, Chunping He, Xuan Luo, Jiajia Zou, Wei He, Wenqian Nong & Cuiwu Lin. (2016) Synthesis, and antioxidant, thrombin-inhibitory, and anticancer activities of hydroxybenzamide derivatives. Applied Biological Chemistry 59:2, pages 271-281.
Crossref
Crossref
Norbert Handler, Andrea Wolkerstorfer & Helmut Buschmann. 2016. Lead Generation. Lead Generation
221
258
.
Anilkumar R KoreMuthian Shanmugasundaram. (2012) Novel serine protease inhibitors. Pharmaceutical Patent Analyst 1:4, pages 457-468.
Crossref
Crossref
Muthusamy Venkatraj, Jonas Messagie, Jurgen Joossens, Anne-Marie Lambeir, Achiel Haemers, Pieter Van der Veken & Koen Augustyns. (2012) Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA). Bioorganic & Medicinal Chemistry 20:4, pages 1557-1568.
Crossref
Crossref
Susan Matthew, Valerie J. Paul & Hendrik Luesch. (2009) Tiglicamides A–C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides. Phytochemistry 70:17-18, pages 2058-2063.
Crossref
Crossref
Stephen H. Kawai, Norman Aubry, Jean-Simon Duceppe, Montse Llinàs-Brunet & Steven R. LaPlante. (2009) Dimethylthiazolidine Carboxylic Acid as a Rigid P3 Unit in Inhibitors of Serine Proteases: Application to Two Targets. Chemical Biology & Drug Design 74:5, pages 517-522.
Crossref
Crossref
Mikael Nilsson, Markku Hämäläinen, Maria Ivarsson, Johan Gottfries, Yafeng Xue, Sebastian Hansson, Roland Isaksson & Tomas Fex. (2009) Compounds Binding to the S2−S3 Pockets of Thrombin. Journal of Medicinal Chemistry 52:9, pages 2708-2715.
Crossref
Crossref
Martyn Frederickson, Owen Callaghan, Gianni Chessari, Miles Congreve, Suzanna R. Cowan, Julia E. Matthews, Rachel McMenamin, Donna-Michelle Smith, Mladen Vinković & Nicola G. Wallis. (2007) Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator. Journal of Medicinal Chemistry 51:2, pages 183-186.
Crossref
Crossref
Gleb D. Perekhodtsev. (2007) Neighborhood Behavior: Validation of Two‐Dimensional Molecular Similarity as a Predictor of Similar Biological Activities and Docking Scores. QSAR & Combinatorial Science 26:3, pages 346-351.
Crossref
Crossref
Jean-Yves Winum, Andrea Scozzafava, Jean-Louis Montero & Claudiu T. Supuran. (2006) Therapeutic potential of sulfamides as enzyme inhibitors. Medicinal Research Reviews 26:6, pages 767-792.
Crossref
Crossref
Tsvetelina I. Lazarova, Lei Jin, Michael Rynkiewicz, Joan C. Gorga, Frank Bibbins, Harold V. Meyers, Robert Babine & James Strickler. (2006) Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa. Bioorganic & Medicinal Chemistry Letters 16:19, pages 5022-5027.
Crossref
Crossref
Bradley C. Pearce, Michael J. Sofia, Andrew C. Good, Dieter M. Drexler & David A. Stock. (2006) An Empirical Process for the Design of High-Throughput Screening Deck Filters. Journal of Chemical Information and Modeling 46:3, pages 1060-1068.
Crossref
Crossref
C. ROSSI, S. HESS, R.W. ECKL, A. DI LENA, A. BRUNO, O. THOMAS & A. POGGI. (2006) Effect of MCM09, an active site‐directed inhibitor of factor Xa, on B16‐BL6 melanoma lung colonies in mice. Journal of Thrombosis and Haemostasis 4:3, pages 608-613.
Crossref
Crossref
Gleb D. Perekhodtsev. (2006) Similarity study of serine proteases inhibitors. Molecular Diversity 10:1, pages 81-83.
Crossref
Crossref
Stefan Dickopf, Michael Frank, Hans-Dieter Junker, Sabine Maier, Günther Metz, Holger Ottleben, Harald Rau, Nathalie Schellhaas, Kristina Schmidt, Renate Sekul, Cecile Vanier, Dirk Vetter, Jörg Czech, Martin Lorenz, Hans Matter, Manfred Schudok, Herman Schreuder, David W. Will & Hans Peter Nestler. (2004) Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa. Analytical Biochemistry 335:1, pages 50-57.
Crossref
Crossref